Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing copies of newspaper advertisement of the financial results of the company for the 4th quarter and year ended March 31 2022 as published in Business Standard and Nava Telagana on June 1 2022.
Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Newspaper Publication
June 1, 2022
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month